By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted April 1, 2019APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted April 1, 2019APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019 READ MORE
